| Announce Date | 11/07/2025 |
| EPS Normalized Actual | $2.92 (Beat by $2.64) |
| EPS GAAP Actual | $2.92 (Beat by $2.64) |
| Revenue Actual | $2.887B |
| Revenue Surprise | Beat by $2887M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.1942 |
| EPS GAAP Estimate | $0.1942 |
| Revenue Estimate | $3.19587138B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.1 | 355.3 | 0.08110835 | 0.11827 | 1 |
| Dec 2028 | -0.25 | -142.12 | -0.3205 | -0.17736 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.93 | 2.21283 | 2.887B | 2% | -89.77M |
| FQ2 2025 (Jun 2025) | -1.76 | -2.1601 | 2.7646B | -23.77% | -357.12M |
| FQ1 2025 (Mar 2025) | -2.78 | -2.78 | 2.6419B | -22.17% | 2641.9M |
| FQ4 2024 (Dec 2024) | -6.54 | -6.54 | 2.3737B | -70.58% | 2373.7M |
| FQ3 2024 (Sep 2024) | -1.2 | -1.2 | 2.8292B | -67.84% | 2829.2M |
| FQ2 2024 (Jun 2024) | -0.58 | -0.58 | 3.4217B | -22.62% | 3421.7M |
| FQ1 2024 (Mar 2024) | -0.51 | -0.51 | 3.2276B | -21.59% | 3227.6M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 4.0491B | -10.62% | 4049.1M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.1942
Consensus Revenue Estimates
3.19587138B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -1.02841 | -- | -1.1399 | -0.91108 | 5 |
| FQ3 2027 (Sep 2027) | 0.891 | -- | 0.72981 | 1.10225 | 2 |
| FQ2 2027 (Jun 2027) | 0.75725 | -- | 0.62026 | 0.93679 | 2 |
| FQ1 2027 (Mar 2027) | -0.0314 | -- | -0.03884479 | -0.02571943 | 2 |
| FQ4 2026 (Oct 2026) | 0.67013 | -- | 0.48367 | 0.91267 | 3 |
| FQ3 2026 (Jul 2026) | 0.75005 | -290.64 | 0.54135 | 1.02152 | 5 |
| FQ2 2026 (Jun 2026) | 0.21827 | 906.34 | 0.17162 | 0.28982 | 4 |
| FQ1 2026 (Mar 2026) | 0.1942 | 1531.51 | 0.15269 | 0.25786 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.8B | -- | 2.55B | 3.03B | 2 |
| FQ3 2027 (Sep 2027) | 4.14B | -- | 3.56B | 4.89B | 2 |
| FQ2 2027 (Jun 2027) | 3.93B | -- | 3.39B | 4.65B | 2 |
| FQ1 2027 (Mar 2027) | 3.74B | -- | 3.22B | 4.42B | 2 |
| FQ4 2026 (Oct 2026) | 3.26B | -- | 2.57B | 4.17B | 2 |
| FQ3 2026 (Jul 2026) | 3.23B | 10.71 | 2.54B | 4.13B | 2 |
| FQ2 2026 (Jun 2026) | 3.25B | 14.85 | 2.71B | 4.07B | 2 |
| FQ1 2026 (Mar 2026) | 3.2B | 17.33 | 2.67B | 4B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.71717 | 2.93 | 2.21283 | 75.52% |
| FQ2 2025 (Jun 2025) | 0.4001 | -1.76 | -2.1601 | 122.73% |
| FQ1 2025 (Mar 2025) | -2.78 | -2.78 | 100% | |
| FQ4 2024 (Dec 2024) | -6.54 | -6.54 | 100% | |
| FQ3 2024 (Sep 2024) | -1.2 | -1.2 | 100% | |
| FQ2 2024 (Jun 2024) | -0.58 | -0.58 | 100% | |
| FQ1 2024 (Mar 2024) | -0.51 | -0.51 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.98B | $2.89B | $-89.77M | -3.11% |
| FQ2 2025 (Jun 2025) | $3.12B | $2.76B | $-357.12M | -12.92% |
| FQ1 2025 (Mar 2025) | $0B | $2.64B | $2641.9M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.37B | $2373.7M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.83B | $2829.2M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.42B | $3421.7M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.23B | $3227.6M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $4.05B | $4049.1M | 100% |